Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and …

Z Ye, Y Wang, LE Colunga-Lozano, M Prasad… - Cmaj, 2020 - Can Med Assoc
BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials

S Ma, C Xu, S Liu, X Sun, R Li, M Mao, S Feng… - Signal transduction and …, 2021 - nature.com
The benefits and harms of corticosteroids for patients with severe coronavirus disease 2019
(COVID-19) remain unclear. We systematically searched PubMed, Embase, and Cochrane …

A Review of the Evidence for Corticosteroids in COVID-19

M Johns, S George… - Journal of pharmacy …, 2022 - journals.sagepub.com
Objective: To review available evidence on corticosteroids in acute respiratory distress
syndrome (ARDS), Coronavirus Disease 2019 (COVID-19), and other viral pneumonias …

A systematic review of corticosteroid treatment for noncritically ill patients with COVID-19

H Shuto, K Komiya, M Yamasue, S Uchida, T Ogura… - Scientific reports, 2020 - nature.com
Abstract The World Health Organization (WHO) has published guidance recommending
systemic corticosteroids for the treatment of patients with severe or critical COVID-19 and no …

The proportion and effect of corticosteroid therapy in patients with COVID-19 infection: A systematic review and meta-analysis

J Wang, W Yang, P Chen, J Guo, R Liu, P Wen, K Li… - PloS one, 2021 - journals.plos.org
Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …

Impact of corticosteroids in coronavirus disease 2019 outcomes: systematic review and meta-analysis

EJ Cano, XF Fuentes, CC Campioli, JC O'Horo… - Chest, 2021 - Elsevier
Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis

D Chaudhuri, K Sasaki, A Karkar, S Sharif… - Intensive care …, 2021 - Springer
Purpose Corticosteroids are now recommended for patients with severe COVID-19 including
those with COVID-related ARDS. This has generated renewed interest regarding whether …

[HTML][HTML] Association of corticosteroids use and outcomes in COVID-19 patients: a systematic review and meta-analysis

H Tlayjeh, OH Mhish, MA Enani, A Alruwaili… - Journal of Infection and …, 2020 - Elsevier
Background To systematically review the literature about the association between systemic
corticosteroid therapy (CST) and outcomes of COVID-19 patients. Methods We searched …

Effects of corticosteroids on Covid-19 patients: A systematic review and meta-analysis on clinical outcomes

FE Chaharom, L Pourafkari, AAE Chaharom… - Pulmonary …, 2022 - Elsevier
Background Covid-19 disease is caused by severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2). Although corticosteroids have shown some promising results in Covid-19 …

Effectiveness of corticosteroids to treat severe COVID-19: a systematic review and meta-analysis of prospective studies

H Li, B Yan, R Gao, J Ren, J Yang - International Immunopharmacology, 2021 - Elsevier
Objectives To assess the effects of corticosteroid therapy for patients with severe
coronavirus disease 2019 (COVID-19). Methods We comprehensively searched articles …